Literature DB >> 2163444

Salivary collagenase. Origin, characteristics and relationship to periodontal health.

V J Uitto1, K Suomalainen, T Sorsa.   

Abstract

Saliva collected from subjects with healthy and with diseased periodontium was assayed for collagenase activity by incubation at 25 degrees C with soluble type I, II or III collagen. The degradation products were analyzed by separation in SDS-polyacrylamide gel electrophoresis followed either by protein staining or by exposure of the dried gel to X-ray film in the case of radioactively labeled type I collagen. Collagenase of vertebrate type was detected in the whole saliva of all subjects but not in parotid, sublingual or submandibular fluids. Most of the collagenase was in the soluble fraction of saliva that also contained factors which both activated and inhibited the enzyme. The salivary collagenase resembled the collagenase of human PMNs and gingival sulcular fluid in its molecular size of 70,000 daltons, in its activation by gold thioglucose and in its tendency to degrade types I and II collagens over type III collagen. Before periodontal treatment, the saliva of periodontitis patients had significantly higher collagenase than after treatment. In periodontitis, collagenase existed mainly in the active form, while in the healthy mouths most of the enzyme was latent but could be activated by sulfhydryl reagents or proteolytically with trypsin, and chymotrypsin but not by human plasma kallikrein or plasmin. In some of the samples from untreated periodontitis patients bacterial collagenase may have been present in small quantities. Most of the collagenase in the saliva from all subjects appeared to originate from PMNs entering the oral cavity through the gingival sulcus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163444     DOI: 10.1111/j.1600-0765.1990.tb01035.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  24 in total

1.  Activation of neutrophil collagenase in periodontitis.

Authors:  R Romanelli; S Mancini; C Laschinger; C M Overall; J Sodek; C A McCulloch
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine.

Authors:  R Gendron; D Grenier; T Sorsa; D Mayrand
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential.

Authors:  K Suomalainen; T Sorsa; L M Golub; N Ramamurthy; H M Lee; V J Uitto; H Saari; Y T Konttinen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 4.  Salivary biomarkers for clinical applications.

Authors:  Lei Zhang; Hua Xiao; David T Wong
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

5.  Bacterial phospholipase C upregulates matrix metalloproteinase expression by cultured epithelial cells.

Authors:  J D Firth; E E Putnins; H Larjava; V J Uitto
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Activated matrix metalloproteinase-8 in saliva as diagnostic test for periodontal disease? A case-control study.

Authors:  Susan Izadi Borujeni; Matthias Mayer; Peter Eickholz
Journal:  Med Microbiol Immunol       Date:  2015-04-05       Impact factor: 3.402

Review 7.  Current developments in salivary diagnostics.

Authors:  Craig S Miller; Joseph D Foley; Alison L Bailey; Charles L Campell; Roger L Humphries; Nicolaos Christodoulides; Pierre N Floriano; Glennon Simmons; Bryon Bhagwandin; James W Jacobson; Spencer W Redding; Jeffrey L Ebersole; John T McDevitt
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

8.  The influence of smoking on the levels of matrix metalloproteinase-8 and periodontal parameters in smoker and nonsmoker patients with chronic periodontitis: A clinicobiochemical study.

Authors:  Namita Gupta; Narinder Dev Gupta; Lata Goyal; Shagufta Moin; Saif Khan; Akash Gupta; Sagar Garg
Journal:  J Oral Biol Craniofac Res       Date:  2015-09-08

9.  In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis.

Authors:  A Lauhio; T Salo; Y Ding; Y T Konttinen; D Nordström; H Tschesche; J Lähdevirta; L M Golub; T Sorsa
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

10.  Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases.

Authors:  T Sorsa; T Ingman; K Suomalainen; M Haapasalo; Y T Konttinen; O Lindy; H Saari; V J Uitto
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.